We showed herein that an NF-κB nuclear translocation inhibitor DHMEQ had a therapeutic effect on CIA in mice, and suppressed the expression of inflammatory molecules and the proliferative activity of TNF-α-stimulated RA FLS. Here, TNF is linked to rheumatoid arthritis.